ArticleFrontiers in immunology2020

Commentary: GSK-3 Inhibition as a Therapeutic Approach Against SARs CoV2: Dual Benefit of Inhibiting Viral Replication While Potentiating the Immune Response.

Andre De Souza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.